USE OF ORAL VP16-213 AS PRIMARY CHEMOTHERAPEUTIC AGENT IN TREATMENT OF GESTATIONAL TROPHOBLASTIC DISEASE

被引：18

作者：

WONG, LC

CHOO, YC

MA, HK

机构：

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1984年 / 150卷 / 08期

关键词：

D O I：

10.1016/0002-9378(84)90382-X

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：924 / 927

页数：4

共 10 条

[1]

BAGSHAWE KD, 1978, ANN ROY COLL SURG, V60, P36

[2]

BAGSHAWE KD, 1976, 1ST P INT C AS FED O, P109

[3]

BAGSHAWE KD, 1978, ADV OBSTET GYNAECOL, V19, P225

[4]

CREAVEN PJ, 1975, CLIN PHARMACOL THER, V18, P221

[5]

DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715

[6]

GOLDSTEIN DP, 1978, OBSTET GYNECOL, V51, P93

[7] TREATMENT OF METASTATIC TROPHOBLASTIC DISEASE - GOOD AND POOR PROGNOSIS [J].

HAMMOND, CB ;

BORCHERT, LG ;

TYREY, L ;

CREASMAN, WT ;

PARKER, RT .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 115 (04) :451-457

[8] TREATMENT OF GESTATIONAL TROPHOBLASTIC DISEASE [J].

JONES, WB ;

LEWIS, JL .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1974, 120 (01) :14-20

[9]

NEWLANDS ES, 1982, CANCER CHEMOTH PHARM, V7, P211

[10] ANTI-TUMOR ACTIVITY OF THE EPIPODOPHYLLIN DERIVATIVE VP16-213 (ETOPOSIDE-NSC-141540) IN GESTATIONAL CHORIOCARCINOMA [J].

NEWLANDS, ES ;

BAGSHAWE, KD .

EUROPEAN JOURNAL OF CANCER, 1980, 16 (03) :401-405

← 1 →